[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
July 24, 1995

Liposomal Amphotericin B Therapy in Disseminated Histoplasmosis

Author Affiliations

Kiel, Germany

Arch Intern Med. 1995;155(14):1556. doi:10.1001/archinte.1995.00430140136020

The incidence of disseminated histoplasmosis in the United States is increasing, especially among immunocompromised patients.1 Conventional treatment consists of amphotericin B, whose